165 related articles for article (PubMed ID: 36384634)
1. Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting.
Rudzinski K; Chan Carusone S; Ceranto A; Ibáñez-Carrasco F; McDonald L; Valentine D; Guta A; Hyshka E; O'Leary W; Cardow A; Strike C
Harm Reduct J; 2022 Nov; 19(1):124. PubMed ID: 36384634
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a specialty HIV hospital in Toronto, Canada: perspectives of people living with HIV.
Rudzinski K; Xavier J; Guta A; Chan Carusone S; King K; Phillips JC; Switzer S; O'Leary B; Baltzer Turje R; Harrison S; de Prinse K; Simons J; Strike C
BMC Public Health; 2021 Jul; 21(1):1482. PubMed ID: 34325681
[TBL] [Abstract][Full Text] [Related]
3. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.
McNeil R; Kerr T; Pauly B; Wood E; Small W
Addiction; 2016 Apr; 111(4):685-94. PubMed ID: 26498577
[TBL] [Abstract][Full Text] [Related]
4. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
Forchuk C; Serrato J; Scott L
Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
[TBL] [Abstract][Full Text] [Related]
5. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
[TBL] [Abstract][Full Text] [Related]
6. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
7. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction.
Fraimow-Wong L; Martín M; Thomas L; Giuliano R; Nguyen OK; Knight K; Suen LW
JAMA Netw Open; 2024 Feb; 7(2):e240229. PubMed ID: 38386317
[TBL] [Abstract][Full Text] [Related]
8. Philanthropy in health professions education research: determinants of success.
Paul R; Hollenberg E; Hodges BD
Med Educ; 2017 May; 51(5):511-520. PubMed ID: 28078667
[TBL] [Abstract][Full Text] [Related]
9. Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV/AIDS: a qualitative study.
McNeil R; Dilley LB; Guirguis-Younger M; Hwang SW; Small W
J Int AIDS Soc; 2014; 17(1):18855. PubMed ID: 24629844
[TBL] [Abstract][Full Text] [Related]
10. Community reinforcement approach (CRA) supported with structured recreation therapy: Experiences of people living with HIV in a pilot substance use treatment program at a specialty hospital.
Rudzinski K; O'Leary W; Perri M; Guimond T; Guta A; Chan Carusone S; Strike C
J Subst Use Addict Treat; 2023 Apr; 147():208974. PubMed ID: 36804349
[TBL] [Abstract][Full Text] [Related]
11. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
[TBL] [Abstract][Full Text] [Related]
12. Living with addiction: the perspectives of drug using and non-using individuals about sharing space in a hospital setting.
Strike C; Guta A; de Prinse K; Switzer S; Chan Carusone S
Int J Drug Policy; 2014 May; 25(3):640-9. PubMed ID: 24679487
[TBL] [Abstract][Full Text] [Related]
13. Visualizing harm reduction: Methodological and ethical considerations.
Switzer S; Guta A; de Prinse K; Chan Carusone S; Strike C
Soc Sci Med; 2015 May; 133():77-84. PubMed ID: 25841098
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Harm Reduction Kits in a Specialty HIV Hospital.
Miskovic M; Chan Carusone S; Guta A; O'Leary B; dePrinse K; Strike C
Am J Public Health; 2018 Oct; 108(10):1363-1365. PubMed ID: 30138074
[TBL] [Abstract][Full Text] [Related]
15. Assessing support for supervised injection services among community stakeholders in London, Canada.
Bardwell G; Scheim A; Mitra S; Kerr T
Int J Drug Policy; 2017 Oct; 48():27-33. PubMed ID: 28666204
[TBL] [Abstract][Full Text] [Related]
16. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
[TBL] [Abstract][Full Text] [Related]
17. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
[TBL] [Abstract][Full Text] [Related]
18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
19. Proposed legislative change mandating retrospective release of identifying information: consultation with donors and Government response.
Hammarberg K; Johnson L; Bourne K; Fisher J; Kirkman M
Hum Reprod; 2014 Feb; 29(2):286-92. PubMed ID: 24319103
[TBL] [Abstract][Full Text] [Related]
20. Gamete donors' expectations and experiences of contact with their donor offspring.
Kirkman M; Bourne K; Fisher J; Johnson L; Hammarberg K
Hum Reprod; 2014 Apr; 29(4):731-8. PubMed ID: 24549216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
